Max Robotics — Global Service Robot Directory + US Certification

About

Brian M. Slomovitz is a leading gynecologic oncologist whose research has fundamentally advanced the surgical management of endometrial and cervical cancers. His work centers on three key areas: minimally invasive surgical techniques, sentinel lymph node mapping, and the safe application of robotic technology in complex patient populations. Slomovitz demonstrated that robotic staging for endometrial cancer is both feasible and safe in elderly women (38 citations), and he established the accuracy of robotic sentinel lymph node detection for endometrial cancer patients (29 citations). He also led the landmark ROCC/GOG-3043 trial (24 citations), a randomized non-inferiority study comparing robotic versus open radical hysterectomy for early-stage cervical cancer—a critical contribution following the LACC trial's controversial findings. His work on defining the learning curve for robotic surgery through cumulative sum analysis and his milestones paper on optimal robotic adoption in gynecology (17 citations) have provided essential frameworks for surgical training and institutional implementation. Through these contributions, Slomovitz has helped establish robotic surgery as a standard approach for gynecologic malignancies, improving perioperative outcomes while maintaining oncologic safety.